Popular:
Haemonetics Corporation (HAE)
Intrinsic Value (DCF)
Current$74.00
→
Intrinsic$56.45
-24%
$32.73$56.45$101.50
Market implies 23% growth for 5 years
HAE trades at a premium to our conservative estimate — investors expect above-average performance.
At $74, the market prices in continued strong cash flow growth (23%) — likely reflecting buybacks, margin stability, and ecosystem strength.
Range: Bear $33 → Bull $101. Current price implies expectations above the base case, closer to bull expectations.
| Discount ↓Growth → | 13% | 15% | 17% | 19% |
|---|---|---|---|---|
| 8% | $72 | $80 | $88 | $97 |
| 10% | $46 | $51 | $56 | $62 |
| 12% | $31 | $35 | $39 | $43 |
| 14% | $21 | $25 | $28 | $31 |
Bull Case
- Bull case ($101) offers 37% upside at 21% growth, 9% discount
Bear Case
- Bear case ($33) implies 56% downside at 14% growth, 12% discount
- Price reflects 23% growth expectations vs 17% historical — high bar to clear
- Trading 24% above base case — execution must exceed assumptions to justify
Loading charts...
5-Year Free Cash Flow Projection
Year 1$167.33M
Year 2$196.55M
Year 3$230.88M
Year 4$271.21M
Year 5$318.58M
Terminal$4.69B
📐 Model Inputs
Growth Rate17.5%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate10.0%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$142.45MTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.